Could a mitochondrial booster calm ulcerative colitis without heavy immune drugs?
NCT ID NCT04276740
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether MitoQ, a supplement that protects cell batteries (mitochondria), can help people with moderate ulcerative colitis (UC) flare-ups. About 79 adults will take either MitoQ or a placebo daily for 24 weeks, alongside standard steroid treatment. The goal is to see if MitoQ improves symptoms and gut healing, potentially offering a safer, cheaper option than strong immune-suppressing drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS FLARE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NHS Lothian
Edinburgh, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.